NPM1 and acute myeloid leukemia: They compared global gene expression of 58 AML NPMc+ samples with prevalence of NK-AML and frequent occurrence of FLT3 mutations, to the group of 20 NK-AMLs without NPM1 mutations and lower occurrence of FLT3 mutations.